Transcene Statistics
Total Valuation
Transcene has a market cap or net worth of TWD 1.14 billion. The enterprise value is 1.81 billion.
| Market Cap | 1.14B |
| Enterprise Value | 1.81B |
Important Dates
The next estimated earnings date is Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Transcene has 38.14 million shares outstanding. The number of shares has increased by 6.79% in one year.
| Current Share Class | 38.14M |
| Shares Outstanding | 38.14M |
| Shares Change (YoY) | +6.79% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 11.92% |
| Owned by Institutions (%) | 2.16% |
| Float | 19.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.65 |
| PB Ratio | 3.58 |
| P/TBV Ratio | 3.61 |
| P/FCF Ratio | 135.92 |
| P/OCF Ratio | 15.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.95, with an EV/FCF ratio of 216.07.
| EV / Earnings | -114.27 |
| EV / Sales | 5.81 |
| EV / EBITDA | 20.95 |
| EV / EBIT | n/a |
| EV / FCF | 216.07 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.28.
| Current Ratio | 0.91 |
| Quick Ratio | 0.34 |
| Debt / Equity | 2.28 |
| Debt / EBITDA | 8.30 |
| Debt / FCF | 86.46 |
| Interest Coverage | 0.12 |
Financial Efficiency
Return on equity (ROE) is -4.86% and return on invested capital (ROIC) is 0.13%.
| Return on Equity (ROE) | -4.86% |
| Return on Assets (ROA) | 0.12% |
| Return on Invested Capital (ROIC) | 0.13% |
| Return on Capital Employed (ROCE) | 0.27% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.81M |
| Profits Per Employee | -193,500 |
| Employee Count | 82 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | -795,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -13.08% |
| 50-Day Moving Average | 31.51 |
| 200-Day Moving Average | 35.99 |
| Relative Strength Index (RSI) | 40.73 |
| Average Volume (20 Days) | 46,723 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Transcene had revenue of TWD 312.22 million and -15.87 million in losses. Loss per share was -0.42.
| Revenue | 312.22M |
| Gross Profit | 92.79M |
| Operating Income | 2.24M |
| Pretax Income | -16.66M |
| Net Income | -15.87M |
| EBITDA | 74.06M |
| EBIT | 2.24M |
| Loss Per Share | -0.42 |
Balance Sheet
The company has 52.84 million in cash and 725.44 million in debt, giving a net cash position of -672.61 million or -17.63 per share.
| Cash & Cash Equivalents | 52.84M |
| Total Debt | 725.44M |
| Net Cash | -672.61M |
| Net Cash Per Share | -17.63 |
| Equity (Book Value) | 318.85M |
| Book Value Per Share | 8.36 |
| Working Capital | -26.43M |
Cash Flow
In the last 12 months, operating cash flow was 71.48 million and capital expenditures -63.09 million, giving a free cash flow of 8.39 million.
| Operating Cash Flow | 71.48M |
| Capital Expenditures | -63.09M |
| Free Cash Flow | 8.39M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 29.72%, with operating and profit margins of 0.72% and -5.08%.
| Gross Margin | 29.72% |
| Operating Margin | 0.72% |
| Pretax Margin | -5.34% |
| Profit Margin | -5.08% |
| EBITDA Margin | 23.72% |
| EBIT Margin | 0.72% |
| FCF Margin | 2.69% |
Dividends & Yields
Transcene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.79% |
| Shareholder Yield | -6.79% |
| Earnings Yield | -1.39% |
| FCF Yield | 0.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Transcene has an Altman Z-Score of 1.1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 5 |